Treatment outcomes in a population-based, 'real-world' cohort of patients with chronic myeloid leukemia (CML). EVIREPRO data base analysis

被引：0

作者：

Pintos, Luis ^{[1
]}

Catalan, Marta ^{[2
]}

Sanabria, Alba ^{[3
]}

Kruss, Mariana ^{[4
]}

Bunzel, Susana

Gatto, Paola

Santini, Fernando

Cinara, Luis ^{[5
]}

Pintos, Noemi ^{[4
]}

Lopez, Anabella ^{[6
]}

Sgromo, Mariana ^{[7
]}

机构：

[1] Hosp Espanol, La Plata, Argentina

[2] Ctr Med Monte Grande, Monte Grande, Argentina

[3] Hosp Eva Peron, Mar Del Plata, Argentina

[4] Sanat Mendez, Buenos Aires, DF, Argentina

[5] Grp Gamma, Rosario, Argentina

[6] Clin Santa Isabel, Buenos Aires, DF, Argentina

[7] Sanat Guemes, Buenos Aires, DF, Argentina

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2020年 / 95卷

关键词：

QUALITY-OF-LIFE; REPORTED OUTCOMES;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P-31

引用

页码：S25 / S26

页数：2

共 50 条

[41] Population pharmacokinetics and pharmacogenetics analyses of imatinib in Chinese patients with chronic myeloid leukemia in a real-world situation
He, Shiyu
Shao, Qianhang
Zhao, Jinxia
Bian, Jialu
Zhao, Yinyu
Hao, Xu
Li, Yuanyuan
Hu, Lei
Liu, Boyu
He, Huan
Huang, Lin
Jiang, Qian
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2023, 92 (05) : 399 - 410
[42] Population pharmacokinetics and pharmacogenetics analyses of imatinib in Chinese patients with chronic myeloid leukemia in a real-world situation
Shiyu He
Qianhang Shao
Jinxia Zhao
Jialu Bian
Yinyu Zhao
Xu Hao
Yuanyuan Li
Lei Hu
Boyu Liu
Huan He
Lin Huang
Qian Jiang
Cancer Chemotherapy and Pharmacology, 2023, 92 (5) : 399 - 410
[43] Real-World Patient Characteristics, Treatment Patterns, and Outcomes in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia in China: A Retrospective Analysis Using a Real-World Database
Liu, Yin
Chen, Yanfei
Xiao, Yue
Huang, Ruijian
Jiang, Feng
Yi, Shuhua
Zhou, Jifang
BLOOD, 2023, 142
[44] Flumatinib for the Treatment of Adult Patients with Resistant or Intolerant Chronic-Phase Chronic Myeloid Leukemia: Results from Real-World Data
Zhou, Xuan
Xu, Na
Wen, Ziyu
Liang, Hanyin
Luo, Dongmei
Chen, Hong
He, Zherou
Gao, Zicheng
Wang, Qiang
Xu, Dan
Liu, Xiaoli
Liu, Qifa
BLOOD, 2023, 142
[45] Cardiovascular and microvascular outcomes with iGlarLixi versus iDegLira: A real-world, population-based cohort study
Cowart, Kevin
Gonzalez, Rachel
Carris, Nicholas W.
DIABETES OBESITY & METABOLISM, 2022, 24 (02): : 348 - 353
[46] First-line treatment outcomes of CML patients in a real-world data setting in Lebanon.
Nasr, Fadi
Yehia, Intissar
El Khoury, Reem
Diab, Saada
Ghoche, Ahmad
Nasr, Lewis
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[47] Primary Nonadherence to Oral Anticoagulants in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort
Rodriguez-Bernal, Clara L.
Peiro, Salvador
Hurtado, Isabel
Garcia-Sempere, Anibal
Sanfelix-Gimeno, Gabriel
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (05): : 440 - +
[48] Real World Analysis Of Duration Of TKI Treatment Among Patients With Chronic Myeloid Leukemia
Henk, Henry J.
Woloj, Mabel
Shapiro, Mark
Whiteley, Jennifer
BLOOD, 2013, 122 (21)
[49] Pomalidomide Use and Kidney Outcomes in Patients With Relapsed/Refractory Multiple Myeloma and Chronic Kidney Disease: A Real-World, Population-Based Cohort Study
Meraz-Munoz, Alejandro
Mian, Hira
Kirkwood, David
Jeyakumar, Nivethika
McCurdy, Arleigh
Tangri, Navdeep
Saskin, Refik
Leung, Nelson
Wald, Ron
Kitchlu, Abhijat
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (11): : e861 - e869
[50] Real-World Analysis of SGLT2 Inhibitors to Prevent Cardiovascular and Kidney Outcomes in Patients with CKD: A Population-Based Cohort Study
Toro, Luis
Valderrama, Josefa
Polanco, Diego
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):

← 1 2 3 4 5 →